Renal Cancer - Results from #3240

Safe use of nivolumab in a patient with renal cell carcinoma and hepatitis B. November 1, 2019

Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy. November 1, 2019

Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia. October 31, 2019

Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. October 31, 2019

Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma. October 31, 2019

Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial. October 31, 2019

Cytoreductive nephrectomy in the current treatment algorithm. October 31, 2019

OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma. October 31, 2019

Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis. October 30, 2019

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. October 30, 2019

The incidence and pattern of renal cell carcinoma recurrence after robotic partial nephrectomy. October 30, 2019

Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. October 29, 2019

Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma. October 29, 2019

Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis. October 29, 2019

Negative prognostic significance of primary cilia, CD8+ tumor infiltrating lymphocytes and PD1+ cells expression in clear cell renal cancer. October 28, 2019

Current and emerging first-line systemic therapies in metastatic clear-cell renal cell carcinoma. October 28, 2019

Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts. October 28, 2019

Pazopanib-Induced Liver Toxicity in Patients With Metastatic Renal Cell Carcinoma: Effect of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety, and Patient Outcomes. October 25, 2019

A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma. October 25, 2019

A review of checkpoint inhibitors in the management of renal cell carcinoma. October 25, 2019

Page 163 of 457